1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Key Pharma News 21 SEPTEMBER 2015

Key Pharma News 21 SEPTEMBER 2015

  • September 2015
  • -
  • Espicom Business Intelligence
  • -
  • 11 pages

Industry Trend Analysis - Amgen Pipeline Needs To Increase Generation Of Marketable Products
Industry Brief - Evotec And Pfizer Enter Tissue Fibrosis Collaboration
Industry Trend Analysis - Acquisitions Will Establish A Firm Cornerstone For Cipla
Industry Brief - Sun Acquires Opiates Business In Australia
Industry Brief - Pfizer Completes Hospira Acquisition
Industry Brief - FDA Approves Octapharma's Nuwiq For Haemophilia A
Industry Brief - AbbVie's Humira Becomes Only FDA Approved Therapy For HS
Industry Trend Analysis - Merck KGaA's Oral Cladribine Will Find Position In Crowded Market
Industry Brief - Takeda's Ixazomib Granted Priority Review for r/r MM
Industry Brief - Alvogen Launches First Generic Rivastigmine Patch In US
Industry Brief - Lupin Launches New Duloxetine Strength
Industry Brief - Biosimilar Etanercept Approved In South Korea
Industry Brief - Oxaydo Launched In US
Industry Trend Analysis - RPI-78M Orphan Status Will Spur Development
Industry Brief - Allergan Settles Namenda XR Patent Litigation With Amneal
Industry Brief - FDA Grants Breakthrough Therapy Designation To Opdivo For Advanced RCC
Industry Trend Analysis - Phase III Aducanumab Trial Is High Risk But High Reward
Industry Brief - Takeda Joins WIPO Re:Search To Accelerate NTD R&D
Industry Brief - Revefenacin Phase III Programme Initiated In COPD Patients

Table Of Contents

Key Pharma News 21 SEPTEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.